Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells

Journal of Immunology

Volumn 194, Issue 8, 2015, Pages 3687-3696

  Dhuban, Khalid Bin ^a,b   D'Henneze, Eva ^a,b   Nashi, Emil ^b   Bar Or, Amit ^c   Rieder, Sadiye ^d   Shevach, Ethan M ^d   Nagata, Satoshi ^e   Piccirillo, Ciriaco A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e SANFORD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; GAMMA INTERFERON; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 17; INTERLEUKIN 2; MESSENGER RNA; PROTEIN FCRL3; PROTEIN TIGIT; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR HELIOS; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; FCRL3 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IKZF2 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; TIGIT PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; GENE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IKZF2 GENE; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SINGLE CELL ANALYSIS; T LYMPHOCYTE SUBPOPULATION; AUTOIMMUNE DISEASE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; PATHOLOGY;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IKAROS TRANSCRIPTION FACTOR; IMMUNOLOGIC MEMORY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY;

EID: 84927619774     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401803     Document Type: Article

References (41)

1. + regulatory T cells in the human immune system. Nat. Rev. Immunol. 10:490-500.
2. D'Hennezel, E., K. Bin Dhuban, T. Torgerson, and C. A. Piccirillo. 2012. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 49:291-302.
3. Buckner, J. H. 2010. Mechanisms of impaired regulation by CD4+CD25+ FOXP3+ regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10:849-859.
4. + T reg cells. J. Exp. Med. 203:1701-1711.
5. Gavin, M. A., T. R. Torgerson, E. Houston, P. DeRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103:6659-6664.
6. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19:345-354.
7. + Treg cells phenotype and function. Methods Mol. Biol. 707:199-218.
8. + cells. J. Immunol. 186:6788-6797.
9. + T regulatory cells. J. Immunol. 184:3433-3441.
10. + human T regulatory cells during in vitro expansion. Blood 119:2810-2818.
11. + T regulatory cell subset in humans". J. Immunol. 190:4439-4440.
12. + T regulatory cell subset in humans. J. Immunol. 190:2001-2008.
13. Yu, X., K. Harden, L. C. Gonzalez, M. Francesco, E. Chiang, B. Irving, I. Tom, S. Ivelja, C. J. Refino, H. Clark, et al. 2009. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10:48-57.
14. Lozano, E., M. Dominguez-Villar, V. Kuchroo, and D. A. Hafler. 2012. The TIGIT/CD226 axis regulates human T cell function. J. Immunol. 188:3869-3875.
15. Zhang, Y., J. Maksimovic, G. Naselli, J. Qian, M. Chopin, M. E. Blewitt, A. Oshlack, and L. C. Harrison. 2013. Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells. Blood 122:2823-2836.
16. H17 cell responses. Immunity 40:569-581.
17. Ehrhardt, G. R., C. M. Leu, S. Zhang, G. Aksu, T. Jackson, C. Haga, J. T. Hsu, D. M. Schreeder, R. S. Davis, and M. D. Cooper. 2007. Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv. Exp. Med. Biol. 596:155-162.
18. Polson, A. G., B. Zheng, K. Elkins, W. Chang, C. Du, P. Dowd, L. Yen, C. Tan, J. A. Hongo, H. Koeppen, and A. Ebens. 2006. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int. Immunol. 18:1363-1373.
19. Davis, R. S., Y. H. Wang, H. Kubagawa, and M. D. Cooper. 2001. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 98:9772-9777.
20. Kochi, Y., K. Myouzen, R. Yamada, A. Suzuki, T. Kurosaki, Y. Nakamura, and K. Yamamoto. 2009. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J. Immunol. 183:5502-5510.
21. Li, F. J., D. M. Schreeder, R. Li, J. Wu, and R. S. Davis. 2013. FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation. Eur. J. Immunol. 43:2980-2992.
22. Kochi, Y., R. Yamada, A. Suzuki, J. B. Harley, S. Shirasawa, T. Sawada, S. C. Bae, S. Tokuhiro, X. Chang, A. Sekine, et al. 2005. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 37:478-485.
23. Bajpai, U. D., L. A. Swainson, J. E. Mold, J. D. Graf, J. B. Imboden, and J. M. McCune. 2012. A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum. 64:2451-2459.
24. Nagata, S., T. Ise, and I. Pastan. 2009. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J. Immunol. 182:7518-7526.
25. Wright, G. W., and R. M. Simon. 2003. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448-2455.
26. Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, E. Schmitt, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5:e38.
27. Polansky, J. K., K. Kretschmer, J. Freyer, S. Floess, A. Garbe, U. Baron, S. Olek, A. Hamann, H. Von Boehmer, and J. Huehn. 2008. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38:1654-1663.
28. + Treg cells correlates positively with disease activity in systemic lupus erythematosus. Arthritis Rheum. 65:2898-2906.
29. Bettelli, E., M. Dastrange, and M. Oukka. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102:5138-5143.
30. Ichiyama, K., H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi. 2008. Foxp3 inhibits RORgt-mediated IL-17A mRNA transcription through direct interaction with RORgt. J. Biol. Chem. 283:17003-17008.
31. H17 lineage-specific transcription factor RORgt. Proc. Natl. Acad. Sci. USA 106:8635-8640.
32. Putnam, A. L., T. M. Brusko, M. R. Lee, W. Liu, G. L. Szot, T. Ghosh, M. A. Atkinson, and J. A. Bluestone. 2009. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58:652-662.
33. + regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1b by downregulating their suppressor functions. J. Immunol. 191:4619-4627.
34. Swainson, L. A., J. E. Mold, U. D. Bajpai, and J. M. McCune. 2010. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J. Immunol. 184:3639-3647.
35. Cai, Q., A. Dierich, M. Oulad-Abdelghani, S. Chan, and P. Kastner. 2009. Helios deficiency has minimal impact on T cell development and function. J. Immunol. 183:2303-2311.
36. Getnet, D., J. F. Grosso, M. V. Goldberg, T. J. Harris, H. R. Yen, T. C. Bruno, N. M. Durham, E. L. Hipkiss, K. J. Pyle, S. Wada, et al. 2010. A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells. Mol. Immunol. 47:1595-1600.
37. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106:1903-1908.
38. H17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE 7:e35572.
39. H17 responses in a Stat3-dependent manner. Science 326:986-991.
40. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595-602.
41. McClymont, S. A., A. L. Putnam, M. R. Lee, J. H. Esensten, W. Liu, M. A. Hulme, U. Hoffmüller, U. Baron, S. Olek, J. A. Bluestone, and T. M. Brusko. 2011. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186:3918-3926.